East vs West: how Japan’s new auditing system differs from the EU
This article was originally published in Clinica
Executive Summary
What are the main challenges for companies when it comes to demonstrating compliance with Japanese medical device requirements, and particularly those that are different to requirements in markets such as the EU? Amanda Maxwell spoke with Eiko Tabuchi of T?V S?D Japan to find out how regulation of medical devices in Japan compares with the EU since the latest Pharmaceutical and Medical Device Act came into force at the end of 2014
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.